KeyIn-1 Is Built on a Strong Clinical Evidence Foundation

KeyIn-1 has been developed and validated using real-world clinical datasets, including inflammatory disease populations and healthy controls, with longitudinal blood samples and clinical follow-up spanning multiple years.